Yunhong Green Cti Ltd. revenue by segment YHGJ

Yunhong Green Cti Ltd. splits its revenue into 4 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Foil Balloons at $12.8 million, 65% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line
FY 2026
Jun 30, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Dec 31, 2019
FY 2018
Dec 31, 2018
FY 2017
Dec 31, 2017
FY 2016
Dec 31, 2016
Revenue
20
20
18
18
18
24
21
32
49
—
—
Foil Balloons
—
13
+10.9%
share 64.8%
12
-2.2%
share 64.1%
12
+8.4%
share 66.1%
11
-40.5%
share 60.2%
18
+8.2%
share 75.7%
17
share 80.0%
—
—
—
—
Other Products
—
6
+3.9%
share 29.5%
6
+9.6%
share 31.2%
5
-0.9%
share 28.7%
5
+53.0%
share 28.6%
3
-0.7%
share 14.0%
3
share 16.1%
—
—
—
—
Film Products
—
1
+33.3%
share 5.7%
1
-8.7%
share 4.7%
1
-54.4%
share 5.2%
2
-14.7%
share 11.3%
2
+196.8%
share 9.9%
1
share 3.8%
—
—
—
—
Latex Balloons
—
—
—
—
—
0
+1242.9%
share 0.4%
0
share 0.0%
—
—
—
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry
Fabricated Rubber Products, NEC (SIC 3060)
Listed as
YHGJ (Nasdaq)
Fiscal year ends
December 31
Incorporated in
IL
Headquarters
Barrington, IL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1042187
Former names
Yunhong CTI Ltd. (until Aug 28, 2023); CTI INDUSTRIES CORP (until Feb 28, 2020)

Other Fabricated Rubber Products, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.